On Oct 29, major Wall Street analysts update their ratings for $Cemex (CX.US)$, with price targets ranging from $6 to $8.9.
J.P. Morgan analyst Adrian Huerta downgrades to a hold rating, and adjusts the target price from $7 to $6.
Barclays analyst Benjamin Theurer maintains with a buy rating, and adjusts the target price from $9 to $8.
RBC Capital analyst Anthony Codling maintains with a hold rating, and adjusts the target price from $6.5 to $6.
Scotiabank analyst Francisco Suarez Savin maintains with a buy rating, and adjusts the target price from $10 to $8.9.
Furthermore, according to the comprehensive report, the opinions of $Cemex (CX.US)$'s main analysts recently are as follows:
The company's fourth-quarter results showed that operating EBITDA was significantly below expectations, coming in at $747M compared to the anticipated $802M. Nevertheless, it is believed that the majority of the negatives are already reflected in the current share price.
The company's recent quarterly performance fell short of the already cautious projections. The anticipation of any substantial fundamental triggers for the company is deferred until at least mid-February, barring a possible rally in the Mexican market. Forecasts for the fourth quarter are also leaning towards the weaker end, with limited clarity regarding the upcoming year's outcomes. Currently, the company's free cash flow is not sufficient to support an increasing dividend in conjunction with reasonable share repurchases.
Here are the latest investment ratings and price targets for $Cemex (CX.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月29日，多家華爾街大行更新了$西麥斯 (CX.US)$的評級，目標價介於6美元至8.9美元。
摩根大通分析師Adrian Huerta下調至持有評級，並將目標價從7美元下調至6美元。
巴克萊銀行分析師Benjamin Theurer維持買入評級，並將目標價從9美元下調至8美元。
加皇資本市場分析師Anthony Codling維持持有評級，並將目標價從6.5美元下調至6美元。
豐業銀行分析師Francisco Suarez Savin維持買入評級，並將目標價從10美元下調至8.9美元。
此外，綜合報道，$西麥斯 (CX.US)$近期主要分析師觀點如下：
公司第四季度的業績顯示，營運廠榷息稅折舊及攤銷前（EBITDA）大幅低於預期，僅爲74700萬美元，而預期爲80200萬美元。儘管如此，大多數負面因素被認爲已經反映在目前的股價中。
公司最近一個季度的表現不及已謹慎的預期。對於公司存在任何重大基本面觸發因素的預期推遲至少到二月中旬，除非墨西哥市場可能出現反彈。第四季度的預測也傾向於弱勢，對於未來一年的結果也缺乏明確性。目前，公司的自由現金流不足以支持隨着合理股份回購而增加的股息。
以下爲今日4位分析師對$西麥斯 (CX.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
